AlphaFold predicted structure
CA5A · P35218

Mean pLDDT
84.5/ 100
Confident
305 residues
Confidence breakdown
- Very high(≥ 90)76%
- Confident(70–90)4%
- Low(50–70)4%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
carbonic anhydrase 5A
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+1 more panels — install the extension to see the full list inline on any page.
hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
epilepsy
duodenal ulcer
urolithiasis
hereditary disease
placenta praevia
osteoarthritis
obstructive sleep apnea syndrome
multinodular goiter
musculoskeletal system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Carbonic anhydrase 5A, mitochondrial
Mitochondrial carbonic anhydrase that catalyzes the reversible conversion of carbon dioxide to bicarbonate/HCO3 (PubMed:24530203, PubMed:8356065). Mitochondria are impermeable to HCO3, and thus this intramitochondrial carbonic anhydrase is pivotal in providing HCO3 for multiple mitochondrial enzymes that catalyze the formation of essential metabolites of intermediary metabolism in the urea and Krebs cycles (PubMed:24530203)
CA5A · P35218

Mean pLDDT
84.5/ 100
Confident
305 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0